Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Jenny, Rowe"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/ff4ea40dd0bf4c94b0123acd8c55e002
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/ffc5858b4f664fb5be9c35507974a8e7
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/97915a2db1804f4c9a2cc438dded432c
Autor:
Viktorija Smutova, Camila Pará, Morgan K. Foret, Nehla Bennamoune, Selly Hung, Catherine Spickler, Renee Riffon, Jenny Rowe, Stephen Festin, Simon Authier
Publikováno v:
International Journal of Toxicology. 42:232-253
The NCG triple immunodeficient mice on a NOD/Nju background lack functional/mature T, B, and NK cells, and have reduced macrophage and dendritic cell function. This study characterized the NCG mouse model for toxicity, engraftment and tumorigenicity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de5ad344ebbf2a042e18047fbc7ee361
https://doi.org/10.1177/10915818221150790
https://doi.org/10.1177/10915818221150790
Autor:
Yu Shen, Marina Konopleva, Warren M. Kati, Keith F. McDaniel, Daniel H. Albert, Michael Boyiadzis, Kathleen A. Dorritie, Neal C. Goodwin, Jenny Rowe, Terrance J. Magoc, Sriram S. Shanmugavelandy, Gaurav Mehta, Debra C. Ferguson, Lina Han, Antonio Cavazos, Qi Zhang, Tamar Uziel, Paul Hessler, Weiguo Feng, Zheng Zha, Xin Lu, Lloyd T. Lam, Vinitha M. Kuruvilla, Emily J. Faivre, Richard J. Bellin, Joshua P. Plotnik, Mai H. Bui, Xiaoli Huang, Xiaoyu Lin, Tianyu Cai, Lu Zhang
Figure S2. ABBV-744 retains strong transcription regulatory activities in AML cells and it did not alter the baseline expression of representative IFN-r or PMA responsive genes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::393d469bbbdbf0d0186b629a919bb58b
https://doi.org/10.1158/1535-7163.22521673.v1
https://doi.org/10.1158/1535-7163.22521673.v1
Autor:
Yu Shen, Marina Konopleva, Warren M. Kati, Keith F. McDaniel, Daniel H. Albert, Michael Boyiadzis, Kathleen A. Dorritie, Neal C. Goodwin, Jenny Rowe, Terrance J. Magoc, Sriram S. Shanmugavelandy, Gaurav Mehta, Debra C. Ferguson, Lina Han, Antonio Cavazos, Qi Zhang, Tamar Uziel, Paul Hessler, Weiguo Feng, Zheng Zha, Xin Lu, Lloyd T. Lam, Vinitha M. Kuruvilla, Emily J. Faivre, Richard J. Bellin, Joshua P. Plotnik, Mai H. Bui, Xiaoli Huang, Xiaoyu Lin, Tianyu Cai, Lu Zhang
Primary patient sample information
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::282ab3dc5a5370970baa604506670681
https://doi.org/10.1158/1535-7163.22521655.v1
https://doi.org/10.1158/1535-7163.22521655.v1
Autor:
Yu Shen, Marina Konopleva, Warren M. Kati, Keith F. McDaniel, Daniel H. Albert, Michael Boyiadzis, Kathleen A. Dorritie, Neal C. Goodwin, Jenny Rowe, Terrance J. Magoc, Sriram S. Shanmugavelandy, Gaurav Mehta, Debra C. Ferguson, Lina Han, Antonio Cavazos, Qi Zhang, Tamar Uziel, Paul Hessler, Weiguo Feng, Zheng Zha, Xin Lu, Lloyd T. Lam, Vinitha M. Kuruvilla, Emily J. Faivre, Richard J. Bellin, Joshua P. Plotnik, Mai H. Bui, Xiaoli Huang, Xiaoyu Lin, Tianyu Cai, Lu Zhang
Supplementary figure and table legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92caa8459e59b7bf1287845739d1ee4a
https://doi.org/10.1158/1535-7163.22521658.v1
https://doi.org/10.1158/1535-7163.22521658.v1
Autor:
Yu Shen, Marina Konopleva, Warren M. Kati, Keith F. McDaniel, Daniel H. Albert, Michael Boyiadzis, Kathleen A. Dorritie, Neal C. Goodwin, Jenny Rowe, Terrance J. Magoc, Sriram S. Shanmugavelandy, Gaurav Mehta, Debra C. Ferguson, Lina Han, Antonio Cavazos, Qi Zhang, Tamar Uziel, Paul Hessler, Weiguo Feng, Zheng Zha, Xin Lu, Lloyd T. Lam, Vinitha M. Kuruvilla, Emily J. Faivre, Richard J. Bellin, Joshua P. Plotnik, Mai H. Bui, Xiaoli Huang, Xiaoyu Lin, Tianyu Cai, Lu Zhang
Dual bromodomain BET inhibitors that bind with similar affinities to the first and second bromodomains across BRD2, BRD3, BRD4, and BRDT have displayed modest activity as monotherapy in clinical trials. Thrombocytopenia, closely followed by symptoms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d00f3fe37fd40d5b4caa87153f1a3bc
https://doi.org/10.1158/1535-7163.c.6543097.v1
https://doi.org/10.1158/1535-7163.c.6543097.v1
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8efb0b91abeb04c7a404a1297fed1337
https://doi.org/10.1136/jitc-2022-sitc2022.0429
https://doi.org/10.1136/jitc-2022-sitc2022.0429
Autor:
Daniel H, Albert, Neal C, Goodwin, Angela M, Davies, Jenny, Rowe, Gerold, Feuer, Michael, Boyiadzis, Kathleen A, Dorritie, Maria, Mancini, Regina, Gandour-Edwards, Brian A, Jonas, Gautam, Borthakur, Ibrahim, Aldoss, David A, Rizzieri, Olatoyosi, Odenike, Thomas, Prebet, Sanjana, Singh, Relja, Popovic, Y U, Shen, Keith F, McDaniel, Warren M, Kati, Dimple A, Modi, Monica, Motwani, Johannes E, Wolff, David J, Frost
Publikováno v:
In vivo (Athens, Greece), vol 36, iss 4
In Vivo
In Vivo
Background/Aim: The therapeutic potential of bromodomain and extra-terminal motif (BET) inhibitors in hematological cancers has been well established in preclinical and early-stage clinical trials, although as of yet, no BET-targeting agent has achie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b4eba30d71a0c94f22fec4754a6d96c
https://escholarship.org/uc/item/8v66m4jc
https://escholarship.org/uc/item/8v66m4jc